Save Nil’s Life: Crowdfunding Campaign Created in Fight Against Spinal Muscular Atrophy (SMA) Type 2

ISTANBUL, May 11, 2020 /PRNewswire/ — A fundraising campaign with a target amount of $2.4 million has been launched through GoFundMe crowdfunding site to save Nil’s life.

Nil Güleç was diagnosed with spinal muscular atrophy (SMA) type 2. To provide their daughter a healthier future, her parents are looking for ways to have access to a gene therapy called “Zolgensma.” The drug is approved for children under two years old and the clock is ticking against Nil as she has just turned 20 months on the 5th of May.

Zolgensma is designed to replace the missing or defective SMN1 gene with a functional copy that produces the SMN protein, thereby improving the function and survival of motor neurons. It seems that Zolgensma can save lives of those who are lucky enough to get it with a single dose of treatment. Yet the drug is currently the most expensive medicine in the world with a cost of 2.15 million US$. This price level is beyond the reach of her family.

“We, as her parents, without knowing that we are carriers of this disease, are broken. It is hard for us to breathe, talk or think. We need support during this fight and help of volunteers who can donate for our little daughter. We wish that Nil will be one of the lucky patients receiving this treatment and will be the hero of her own fairytale,” Nil’s parents remarked.

Nil’s parents have created a web site to reach the financing of the gene therapy. The name of the web site is originated from the donation campaign that has been initiated through “GoFundMe” crowd funding site in America: https://www.savingnil.com/en. Savingnil.com consists of artworks of esteemed painters, photographers, digital designers besides those who are engaged with art apart from their main profession. Artworks exhibited in this web site are all dedicated to Nil. The income gained from the sales on this site will be used for Nil’s treatment. This web site is another hope for Nil.

Volunteers can either donate through GoFundMe page or buy an artwork through the web site.

Spinal Muscular Atrophy (SMA) is a neuromuscular disease, which is manifested by a progressive loss of muscle strength that affects the ability to walk, swallow and breathe. And it is the number one genetic cause of infant mortality. It is caused by a mutation in the survival gene of motor neurons 1 (SMN1). This gene is responsible for the production of a protein that is critical for the nerves that control our muscles. Without this protein, these neurons cannot function properly and die at any given time.

For more information about donation, please go on https://www.gofundme.com/f/save-nil039s-life.

Photo – http://vacancies.healthtechnologynet.com/wp-content/uploads/2020/05/Save_Nils_Life_GoFundMe.jpg

Contact:
Nihan Güleç
anihansg@gmail.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/save-nils-life-crowdfunding-campaign-created-in-fight-against-spinal-muscular-atrophy-sma-type-2-301056235.html

SOURCE Save Nil’s Life

Staff

Recent Posts

Castle Biosciences Announces Updates to its Board of Directors

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that…

10 hours ago

Akanda Corp. Announces Closing of Underwritten Public Offering

London, United Kingdom--(Newsfile Corp. - March 27, 2024) - On March 24, 2024, Akanda Corp.…

10 hours ago

Dermata to Present at the Emerging Growth Conference on April 3, 2024

- Dermata to provide a corporate update followed by a live question and answer session…

10 hours ago

CorDx Receives Emergency Use Authorization (EUA) for 10-Min Flu A/B & COVID-19 Test

FDA Grants CorDx Emergency Use Authorization for Multi-Target Rapid Test for Flu A/B & COVID-19SAN…

13 hours ago

Greenway Health and DrFirst Partner to Improve Medication Adherence and Improve Patient Outcomes through Technology

TAMPA, Fla., March 27, 2024 /PRNewswire/ -- Greenway Health, a leading health information technology services provider, announced its strategic…

16 hours ago

NextGen Healthcare Named to Newsweek List of America’s Most Trustworthy Companies for Third Year in a Row

List Based on an Independent Survey of 25,000 U.S. ResidentsREMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, a…

16 hours ago